Clinical Research Directory
Browse clinical research sites, groups, and studies.
International Severe CRSwNP Registry 2024-2028
Sponsor: Vibeke Backer
Summary
The objective of the study is to collect real-life data worldwide, which already have been collected in national databases, to merge the data and the knowledge with the focus of better care for the individual patients, more efficient use of the hospital cost of biologics and working for "personalized medicine".
Official title: InternatioNal seVerE CRSwNP Registry (INVENT) 2024-2028
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
3000
Start Date
2025-03-31
Completion Date
2032-01
Last Updated
2025-04-08
Healthy Volunteers
No
Interventions
Biologic drugs
Biologic drugs including Mepolizumab, Dupilumab, Omalizumab, Tezepelumab, or future monoclonal antibodies
Locations (1)
Department of Rhinolaryngology Head & Neck surgery and Audiology
Copenhagen, Denmark, Denmark